Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson's disease;Nulidade de GSTT1/GSTM1 relacionada à pesticidas associa-se com doença de Parkinson

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 8, 2013, Pages 527-532

  Pinhel, Marcela Augusta de Souza ^a,b   Sado, Caroline Leiko ^a,c   Longo, Gabriela dos Santos ^a,b   Gregório, Michele Lima ^a,b   Amorim, Gisele Sousa ^a,b   Florim, Greiciane Maria da Silva ^a,b   Mazeti, Camila Montoro ^a,b   Martins, Denise Poltronieri ^a,b   Oliveira, Fábio de Nazaré ^a,b   Nakazone, Marcelo Arruda ^a,d   Tognola, Waldir Antonio ^a,b   Souza, Dorotéia Rossi Silva ^a,b  

^a Departamento de Biologia Molecular   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL DE BASE   (Brazil)

Author keywords

Glutathione transferase; Parkinson disease; Polymorphism genetic; Xenobiotics

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PESTICIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SIMILARITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; SMOKING HABIT;

EID: 84883419319     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130076     Document Type: Article

References (30)

1. Singh M, Khan AJ, Shah PP, et al. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008;312:131-138.
2. Korff A, Pfeiffer B, Smeyne M, et al. Alterations in glutathione S-transferase pi expression following exposure to MPP+-induced oxidative stress in the blood of Parkinson's disease patients. Parkinsonism Relat Disord 2011;17:765-768.
3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-386.
4. European Parkinson's Disease Association (EPDA). Priceless partnerships: annual report 2009 [cited 2013 May 3]. Available from: http://www.epda.eu.com/EasysiteWeb/getresource.axd?AssetID=10682&type=full&servicetype=Attachment
5. Brasil. Ministério da Saúde. Departamento de Informática do SUS (DATASUS). Protocolo clínico e diretrizes terapêuticas: Doença de Parkinson. Portaria SAS/MS no 228, de 10 de maio de 2010 [cited 2013 May 3]. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/pcdt_doenca_parkinson_livro_2010.pdf
6. Moreira PI, Zhu X, Lee HG, et al. The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease. Mech Ageing Dev 2006;127:501-506.
7. Vilar R, Coelho H, Rodrigues E, et al. Association of A313G polymorphism (GSTP1*B) in the glutathione S-transferase P1 gene with sporadic Parkinson's disease. Eur J Neurol 2007;14:156-161.
8. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000;1502:139-144.
9. Maimone D, Dominici R, Grimaldi LME. Pharmacogenetics of neurodegenerative diseases. Eur J Pharmacol 2001;413:11-29.
10. Benmoyal-Segal L, Soreq H. Gene-environment interactions in sporadic Parkinson's disease. J Neurochem 2006;97:1740-1755.
11. Kiyohara C, Miyake Y, Koyanagi M, et al. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Parkinsonism Relat Disord 2010;16:447-452.
12. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 2000;21:435-440.
13. Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007;64:990-997.
14. Uzunoglu S, Acar H, Okudan N, et al. Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease. Arch Dermatol Res 2006;297:289-293.
15. Onaran I, Osaydin A, Akbas F, et al. Are individuals with glutathione S-transferase GSST1 null genotype more susceptible to in vitro oxidative damage? J Toxicol Environ Health A 2000;59:15-26.
16. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 1999;18:141-145.
17. Pena SD, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic anscestry of Brazilians. Braz J Med Biol Res 2009;42:870-876.
18. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-376.
19. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 1998;44:1748-1750.
20. Rossini A, Rapozo DC, Amorim LM, et al. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 2002;1:233-240.
21. Shaikh RS, Amir M, Masood AI, et al. Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence. Environ Toxicol Pharmacol 2010;30:76-79.
22. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci 2003;100:177-182.
23. Tan EK, Khajavi M, Thornby JI, et al. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000;55:533-538.
24. De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 1998;352:1986-1987.
25. Wahner AD, Glatt CE, Bronstein JM, Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett 2007;413:274-278.
26. Nisticò R, Mehdawy B, Piccirilli S, Mercuri N. Paraquat- and rotenone-induced models of Parkinson's disease. Int J Immunopathol Pharmacol 2011;24:313-322.
27. Xiong N, Long X, Xiong J, et al. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models. Crit Rev Toxicol 2012;42:613-632.
28. Reale M, Pesce M, Priyadarshini M, Kamal MA, Patruno A. Mitochondria as an easy target to oxidative stress events in Parkinson's disease. CNS Neurol Disord Drug Targets 2012;11:430-438.
29. Yuille M, Condie A, Hudson C, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 2002;99:4216-4218.
30. Morimoto LM, White E, Newcomb PA. Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 2003;158:259-263.